166 related articles for article (PubMed ID: 38004390)
41. Triaryl dicationic DNA minor-groove binders with antioxidant activity display cytotoxicity and induce apoptosis in breast cancer.
Nafie MS; Arafa K; Sedky NK; Alakhdar AA; Arafa RK
Chem Biol Interact; 2020 Jun; 324():109087. PubMed ID: 32294457
[TBL] [Abstract][Full Text] [Related]
42. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
Kassab AE; Hassan RA
Bioorg Chem; 2018 Oct; 80():531-544. PubMed ID: 30014921
[TBL] [Abstract][Full Text] [Related]
43. Bioactivity-Guided Synthesis: In Silico and In Vitro Studies of
Khushal A; Farooq U; Khan S; Rasul A; Wani TA; Zargar S; Shahzad SA; Bukhari SM; Khan NA
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764324
[TBL] [Abstract][Full Text] [Related]
44. Anticancer activity of newly synthesized 1,1-disubstituted cyclohexane-1-carboxamides: in vitro caspases mediated apoptosis activators in human cancer cell lines and their molecular modeling.
Abd-Allah WH; Salman A; Sabry Saad S
Drug Dev Res; 2019 Nov; 80(7):933-947. PubMed ID: 31343754
[TBL] [Abstract][Full Text] [Related]
45. Design, Synthesis, Molecular Modeling, and Anticancer Evaluation of New VEGFR-2 Inhibitors Based on the Indolin-2-One Scaffold.
Abdelgawad MA; Hayallah AM; Bukhari SNA; Musa A; Elmowafy M; Abdel-Rahman HM; Abd El-Gaber MK
Pharmaceuticals (Basel); 2022 Nov; 15(11):. PubMed ID: 36422546
[TBL] [Abstract][Full Text] [Related]
46. Design, Synthesis and Evaluation of Novel Derivatives of Curcuminoids with Cytotoxicity.
Chen CY; Lien JC; Chen CY; Hung CC; Lin HC
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830055
[TBL] [Abstract][Full Text] [Related]
47. Design, synthesis, molecular docking and in silico ADMET profile of pyrano[2,3-d]pyrimidine derivatives as antimicrobial and anticancer agents.
Abd El-Sattar NEA; El-Adl K; El-Hashash MA; Salama SA; Elhady MM
Bioorg Chem; 2021 Oct; 115():105186. PubMed ID: 34314914
[TBL] [Abstract][Full Text] [Related]
48. A quinoxaline-based derivative exhibited potent and selective anticancer activity with apoptosis induction in PC-3 cells through Topo II inhibition.
Elsakka MEG; Tawfik MM; Barakat LAA; Nafie MS
J Biomol Struct Dyn; 2024 Mar; ():1-19. PubMed ID: 38486408
[TBL] [Abstract][Full Text] [Related]
49. Design, synthesis and evaluation of 4,7-disubstituted 8-methoxyquinazoline derivatives as potential cytotoxic agents targeting β-catenin/TCF4 signaling pathway.
Neogi K; Murumkar PR; Sharma P; Yadav P; Tewari M; Karunagaran D; Nayak PK; Yadav MR
Transl Oncol; 2022 May; 19():101395. PubMed ID: 35325837
[TBL] [Abstract][Full Text] [Related]
50. Antiproliferative and Pro-Apoptotic Effects of Thiazolo[3,2-b][1,2,4]triazoles in Breast and Cervical Cancer Cells.
Khan I; Zaib S; Javed M; Rashid F; Iqbal J; Ibrar A
Anticancer Agents Med Chem; 2021 Oct; 21(16):2181-2191. PubMed ID: 33573578
[TBL] [Abstract][Full Text] [Related]
51. Rationale design and synthesis of new apoptotic thiadiazole derivatives targeting VEGFR-2: computational and
Elgammal WE; Elkady H; Mahdy HA; Husein DZ; Alsfouk AA; Alsfouk BA; Ibrahim IM; Elkaeed EB; Metwaly AM; Eissa IH
RSC Adv; 2023 Dec; 13(51):35853-35876. PubMed ID: 38116168
[TBL] [Abstract][Full Text] [Related]
52. New benzenesulfonamide scaffold-based cytotoxic agents: Design, synthesis, cell viability, apoptotic activity and radioactive tracing studies.
Nissan YM; Mohamed KO; Ahmed WA; Ibrahim DM; Sharaky MM; Sakr TM; Motaleb MA; Maher A; Arafa RK
Bioorg Chem; 2020 Mar; 96():103577. PubMed ID: 31978683
[TBL] [Abstract][Full Text] [Related]
53. Novel benzimidazole derivatives: Synthesis, in vitro cytotoxicity, apoptosis and cell cycle studies.
Atmaca H; İlhan S; Batır MB; Pulat ÇÇ; Güner A; Bektaş H
Chem Biol Interact; 2020 Aug; 327():109163. PubMed ID: 32534988
[TBL] [Abstract][Full Text] [Related]
54. Novel thienopyrimidine analogues as potential metabotropic glutamate receptors inhibitors and anticancer activity: Synthesis, In-vitro, In-silico, and SAR approaches.
Khedr MA; Abu-Zied KM; Zaghary WA; Aly AS; Shouman DN; Haffez H
Bioorg Chem; 2021 Apr; 109():104729. PubMed ID: 33676314
[TBL] [Abstract][Full Text] [Related]
55. Cell Growth Inhibition, DNA Fragmentation and Apoptosis-Inducing Properties of Household-Processed Leaves and Seeds of Fenugreek (
Salam SGA; Rashed MM; Ibrahim NA; Rahim EAA; Alsufiani HM; Mansouri RA; Afifi M; Al-Farga A
Curr Issues Mol Biol; 2023 Jan; 45(2):936-953. PubMed ID: 36826005
[TBL] [Abstract][Full Text] [Related]
56. Design and Synthesis of Novel Anti-Proliferative Emodin Derivatives and Studies on their Cell Cycle Arrest, Apoptosis Pathway and Migration.
Yang K; Jin MJ; Quan ZS; Piao HR
Molecules; 2019 Mar; 24(5):. PubMed ID: 30832378
[TBL] [Abstract][Full Text] [Related]
57. Nicotinonitrile-derived apoptotic inducers: Design, synthesis, X-ray crystal structure and Pim kinase inhibition.
Aboukhatwa SM; Ibrahim AO; Aoyama H; Al-Behery AS; Shaldam MA; El-Ashmawy G; Tawfik HO
Bioorg Chem; 2022 Dec; 129():106126. PubMed ID: 36108589
[TBL] [Abstract][Full Text] [Related]
58. Anticancer potential of Phoenix dactylifera L. seed extract in human cancer cells and pro-apoptotic effects mediated through caspase-3 dependent pathway in human breast cancer MDA-MB-231 cells: an in vitro and in silico investigation.
Khan MA; Singh R; Siddiqui S; Ahmad I; Ahmad R; Upadhyay S; Barkat MA; Ali AMA; Zia Q; Srivastava A; Trivedi A; Husain I; Srivastava AN; Mishra DP
BMC Complement Med Ther; 2022 Mar; 22(1):68. PubMed ID: 35291987
[TBL] [Abstract][Full Text] [Related]
59. Design, Synthesis, In Silico and In Vitro Studies of New Immunomodulatory Anticancer Nicotinamide Derivatives Targeting VEGFR-2.
Yousef RG; Eldehna WM; Elwan A; Abdelaziz AS; Mehany ABM; Gobaara IMM; Alsfouk BA; Elkaeed EB; Metwaly AM; Eissa IH
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807326
[TBL] [Abstract][Full Text] [Related]
60. New 5-Aryl-1,3,4-Thiadiazole-Based Anticancer Agents: Design, Synthesis, In Vitro Biological Evaluation and In Vivo Radioactive Tracing Studies.
El-Masry RM; Essa BM; Selim AA; El-Emam SZ; Mohamed KO; Sakr TM; Kadry HH; Taher AT; Abou-Seri SM
Pharmaceuticals (Basel); 2022 Nov; 15(12):. PubMed ID: 36558927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
